Organic compounds -- part of the class 532-570 series inventions 08/07

20070203337 - Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase: in which either Y is a methylene (CH2) and X is chosen from the following groups: O, NH, (C1-C4) N-Alkyl, N-Bn, N-Ph, N-(2-Py), N-(3-Py), N-(4-Py), N-2-pyrimidyl, N-5-pyrimidyl, S, SO, SO2, CH2 or CHPh; or Y is a carbonyl (C═O) and X is chosen from the following groups: NH, N-Ph, N-(2-Py),... Agent: Ross J. Oehler Sanofi-aventis U.s. LLC

20070203338 - Novel carboxylic acid derivatives, their preparation and use:

20070203339 - Process for preparation of cyclic prodrugs of pmea and pmpa:

20070203340 - Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines: A process for preparing substituted 5-amino-pyrazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pyrimidine compounds having an aminoalkyl substituent at the 7-position is disclosed, wherein the pyrimidine ring is cyclized using a cyanating agent.... Agent: Schering-plough Corporation Patent Department (k-6-1, 1990)

20070197782 - 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases: The present invention provides 3-hydroxyphenyl-2,4-pyrimidinediamine compounds of formula I, as well as related compositions and methods for treating a variety of autoimmune diseases.... Agent: Rigel Pharmaceuticals Inc.

20070197783 - Compositions and methods of treating cell proliferation disorders: The invention relates to compounds and methods for treating cell proliferation disorders.... Agent: Mintz, Levin, Cohn, Ferris, Glovsky And Popeo, P.C.

20070197784 - Process for producing dioxolane nucleoside analogues: The present invention relates to a process conducted in a single reaction vessel for producing a dioxolane nucleoside analogue of formula I or a pharmaceutically acceptable salt thereof; the process comprising the steps of adding a Lewis acid, a silylating agent and a non-silylated purine or pyrimidine base or an... Agent: Millen, White, Zelano & Branigan, P.C.

20070197785 - Method for inhibiting polymerization of (meth) acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor: This invention relates to a method for inhibiting polymerization of (meth)acrylic acid and its esters using a polymerization inhibitor which comprises at least one reduced halide-content azine dye-based compound. A process for producing reduced halide-content azine dye-based compounds using ion exchange resin technology is also provided.... Agent: Rohm And Haas Company Patent Department

20070197786 - Enantiomerically pure opioid diarylmethylpiperazine: (−)3-((S)-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)(3-thienyl)methyl)phenol and pharmaceutically acceptable esters or salts thereof, in essentially enantiomerically pure form have utility as a therapeutic agent for mediating analgesia and treating cardiac disorders, alcohol addiction, drug overdose, cough, lung edema, diarrhea, respiratory, and gastro-intestinal disorders.... Agent: Moore & Van Allen PLLC

20070191603 - Novel bicyclic sulfonamide derivatives which are l-cpt1 inhibitors: P

20070191604 - Novel compounds that are erk inhibitors: and the pharmaceutically acceptable salts and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using... Agent: Schering-plough Corporation Patent Department (k-6-1, 1990)

20070191605 - Method for the production of ling-chained quaternary ammonium oxalates and ammonium hydrogenoxalates: The present invention relates to a novel method for the production of long-chained quaternary ammonium oxalates and of long-chained quaternary ammonium hydrogen oxalates by reacting amines with dimethyl carbonate and further reacting the intermediate product with oxalic acid or oxalic acid dihydrate.... Agent: Clariant Corporation Intellectual Property Department

20070191606 - 2,2-bis(4-hydroxyphenyl)-alkyl onium salt and process for the preparation thereof: The present invention provides novel 2,2-bis(4-hydroxyphenyl)-alkyl onium salts as illustrated by 2,2-bis(4-hydroxyphenyl)-tridecyl(1,2-dimethylimidazolium)bromide and a process for preparation thereof by hydroxyalkylating acetoacetate to the corresponding hyroxyalkylacetoacetate, dealkoxycarbonylating the hydroxyalkyl acetoacetate to ω-hydroxyalkan-2-one and contacting the ω-hydroxyalkan-2-one with phenol in the presence of an acidic catalyst to give 2,2-bis(4-hydroxyphenyl)alkanol, brominating the 2,2-bis(4-hydroxyphenyl)alkanol... Agent: Greenlee Winner And Sullivan P C

20070185324 - Nitrogen-containing bicyclic heteroaryl compounds and methods of use: P

20070185325 - 2,4-dioxopyrimidine-based mesoionic pigments: wherein the two monomer-units are linked with each other either via R3 or via R4; the ring A is a five-or six-membered heteroaromatic ring, one of the groups R3 or R4 is an unsubstituted or substituted phenylene radical, the remaining group R3 or R4 is a C1-C4 alkyl, C5-C6 cycloalkyl,... Agent: Clariant Corporation Intellectual Property Department

20070185326 - Heterocyclic compound: wherein R1 is a halogen, nitro, an alkyl, etc.; R2 is hydrogen, an alkyl, etc.; Ring A is 2-oxo-4-imidazolin-3,4-diyl, etc.; Ring B is a cycloalkyl, monocyclic saturated heterocyclic group; X is CH, N; Y is a single bond, CO, SO2; Z is O, NH, etc.; and Ring C is an... Agent: Birch Stewart Kolasch & Birch

20070185327 - Preparation of substituted quinoxalines: e

20070179294 - Multicore indazolinone library: There is provided a method to convert O-functionalized indazolinone-derivatives to the corresponding N2-functionalized indazolinone derivatives, by use of microwave energy or a transition metal catalyst. A preferred catalyst is palladium tetrakis. The method described allows the creation of a library of chemical compounds which can be screened for biological activity.... Agent: Drinker Biddle & Reath Attn: Intellectual Property Group

20070179295 - Triazolopyrimidines: The invention relates to novel triazolopyrimidines of formula (I), in which R1, R2, R3, R4 and X are defined as cited in the description, to a method for producing said substances and to their use for controlling undesirable micro-organisms. The invention also relates to novel intermediate products of the formulae... Agent: Sterne, Kessler, Goldstein & Fox P.l.l.c.